New York – August 30, 2016 – Cooley advised the placement agents on Advaxis, Inc.’s registered direct offering of 2,244,443 shares of common stock resulting in gross proceeds of approximately $30.3 million.
Advaxis is a clinical-stage biotech company developing multiple cancer immunotherapies based on its proprietary Lm Technology.
Jefferies and Barclays acted as lead placement agents for the offering. Cantor Fitzgerald & Co., Guggenheim Securities, Janney Montgomery Scott and H.C. Wainwright & Co. acted as co-placement agents.
The Cooley corporate and securities team advising the placement agents was comprised of Div Gupta, Charlie Kim, Brent Siler, Jonie Kondracki and Denny Won.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 900 lawyers across 12 offices in the United States, China and Europe.